Sep 23, 2020
BIVDA Press Release – For Immediate Release --- BIVDA IVD Market Audit Results Show COVID-19 Impact Report shows substantial impact of COVID-19 pandemic on other diagnostic tests Some diagnostic revenues down by as much as 90% COVID-19 revenues skyrocket The BIVDA Market Audit Report for the first half of 2020 has been published to participants. Twenty seven companies submitted revenue data which has been consolidated into a detailed report on the market size an...
Sep 16, 2020
Press Release – BIVDA Calls for Diagnostics Sector Support in Spending Review Submission For Immediate Release ---- The British In-Vitro Diagnostics Association has called on the Chancellor, Rishi Sunak, to put support for the UK IVD industry front of centre of the forthcoming Comprehensive Spending Review. As we begin to recover from the COVID-19 pandemic and look ahead to future health challenges, a strong, efficient and well supported IVD industry will be critical if the ...
Sep 01, 2020
For immediate releaseBIVDA joins call to urge Prime Minister to protect charity research BIVDA has joined over 30 top pharmaceutical, IVD and health tech bodies who have signed an open letter to the Prime Minister urging Government to provide financial support for medical research charities. The Life Sciences-Charity Partnership Fund, developed by the Association of Medical Research Charities (AMRC), has support from the likes of AstraZeneca, Roche and Eli Lilly. All are calling on Government to...
Aug 26, 2020
FOR IMMEDIATE RELEASE BIVDA Joins key DIT Trade Advisory Group on Life Sciences International Trade Secretary Liz Truss has today launched 11 new trade advisory groups (TAGs), as part of a major new business engagement drive designed to support the UK’s ambitious trade negotiations. As trade talks with Japan, the US, Australia and New Zealand intensify, the Trade Secretary is stepping up engagement with key industries across Britain, including life sciences, farming, manufacturin...
Jul 30, 2020
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.
Jul 16, 2020
New England Biolabs’ SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 MinutesThe research use only kit can be used as a simple alternative to RT-qPCR for SARS-CoV-2 analysisIPSWICH, MA (July 6, 2020): New England Biolabs® (NEB®) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV-2 RNA. The kit serv...
Jul 09, 2020
Please find attached and below a press statement from BIVDA Chief Executive Doris-Ann Williams, commenting on the Chancellor’s financial statement. BIVDA Statement on Chancellor’s Summer Economic Update 9th July 2020 For Immediate Release The Chief Executive of BIVDA, Doris-Ann Williams, has commented on the economic announcements in the Chancellor’s Summer Economic Update. Looking at the measures announced to support job creation, Doris-Ann said; &ldq...
May 14, 2020
Dear All Please see below and attached a press release from BIVDA with a comment from our Chief Executive Doris-Ann Williams, regarding the approval of the COVID-19 antibody test by Public Health England. Kind regards Jon PRESS RELEASE FROM BIVDA FOR IMMEDIATE RELEASE BIVDA Comments on COVID-19 antibody test authorisation by Public Health EnglandBIVDA is delighted to see that an IVD is again making headlines this morning as testing continues to underpin the f...
May 01, 2020
Please see below a short statement from BIVDA Chief Executive Doris-Ann Williams regarding the Government’s meeting of it’s testing target. “I am delighted that the Government has reached its target of 100,000 tests a day. This is a significant achievement by all involved, and I want to congratulate all BIVDA members, officials, health personnel and lab staff who have played a part in making this possible. We are now well on the way to having the infrastructure to s...
Apr 22, 2020
PRESS RELEASE22nd April 2020Stream Bio, a company that develops and manufactures a range of transformative bioimaging molecular probes, is delighted to announce a new joint venture with MIP Diagnostics Ltd., a world leader in molecular imprinting for diagnostic and other applications. The collaborative project will focus on the development of a COVID-19 (or SARS-Cov-2) antigen reagent for assays, a lateral flow Rapid Diagnostic Test (RDT) and an ‘ELISA’ type assay for high throughput...